NDC properties for "0.4 ML Cyltezo 50 MG/ML Prefilled Syringe" (RxCUI 2640894)
About this data
The tables show NDC propoerties for 0.4 ML Cyltezo 50 MG/ML Prefilled Syringe with the RxCUI 2640894
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.4 ML Cyltezo 50 MG/ML Prefilled Syringe (RxCUI 2640894)
| BLA | BLA761058 |
|---|---|
| MMSL_CODE | BD39574 |
| RxCUI | 2640894 |
| SPL_SET_ID | 115ea79b-7209-7f19-b35d-36ec0828fbf5 |
| Prescribable Synonym | CYLTEZO 20 MG in 0.4 ML Prefilled Syringe |
| RXNAV_STR | 0.4 ML Cyltezo 50 MG/ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] |
| RxNorm Synonym | 0.4 ML Cyltezo 50 MG/ML Prefilled Syringe |
| RxNorm Synonym | Cyltezo 20 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2640894) |
NDC Properties
NDC Item 00597040510
| NDC 9 | 0597-0405 |
|---|---|
| NDC 10 | 0597-0405-10 |
| NDC Item | 00597040510 |
| Packaging | 1 KIT in 1 CARTON (0597-0405-10) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0405 |
NDC Item 00597040580
| NDC 9 | 0597-0405 |
|---|---|
| NDC 10 | 0597-0405-80 |
| NDC Item | 00597040580 |
| Packaging | 2 KIT in 1 CARTON (0597-0405-80) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0405 |
NDC Item 00597040510
| NDC 9 | 0597-0405 |
|---|---|
| NDC 10 | 0597-0405-10 |
| NDC Item | 00597040510 |
| Packaging | 1 KIT in 1 CARTON (0597-0405-10) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0405 |
NDC Item 00597040580
| NDC 9 | 0597-0405 |
|---|---|
| NDC 10 | 0597-0405-80 |
| NDC Item | 00597040580 |
| Packaging | 2 KIT in 1 CARTON (0597-0405-80) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0405 |